Medtronic PLC

NYSE:MDTUnited States

Today

Show headlines and story abstract

• DJ Medtronic Recalls MiniMed Insulin Pumps Over Battery Issues -- Update, from 7 hours ago by Dow Jones

  7 hours ago by Dow Jones
  Companies Mentioned: MDT
  
  By Dean Seal
  
  Medtronic has issued a voluntary recall on some of its insulin pumps over concerns about the length of their battery life.
  
  The Dublin-based medical-device maker said Friday that customers of its MiniMed 600 series or 700 series insulin pumps have reported shortened battery life in pumps that have been dropped or experienced some kind of physical impact that damaged internal components.
  

• Medtronic Issues New Safety Alert in Voluntary Recall of Insulin Pumps, from 8 hours ago by MT Newswires

  8 hours ago by MT Newswires
  Companies Mentioned: MDT
  07:57 AM EDT, 10/04/2024 (MT Newswires) -- Medtronic (MDT) said Friday that it issued an updated safety alert regarding its MiniMed 600 series or 700 series insulin pumps to inform users about certain situations that may reduce pump battery life, po...

• DJ Medtronic Recalls MiniMed Insulin Pumps Over Battery Issues, from 8 hours ago by Dow Jones

  8 hours ago by Dow Jones
  Companies Mentioned: MDT
  
  By Dean Seal
  
  Medtronic has issued a voluntary recall on some of its insulin pumps over concerns about the length of their battery life.
  
  The Dublin-based medical-device maker said Friday that customers of its MiniMed 600 series or 700 series insulin pumps have reported shortened battery life in pumps that have been dropped or experienced some kind of physical impact that damaged internal components.
  

• DJ Medtronic Voluntarily Recalls Insulin Pumps Due To Risk Of Shortened Battery Life -- MarketWatch, from 9 hours ago by Dow Jones

  9 hours ago by Dow Jones
  Companies Mentioned: MDT
  
  Medtronic Plc (MDT) announced a voluntary recall Friday to notify users of its insulin pumps of potential risks of shortened pump battery life, telling them to contact the company for pump replacement if affected. The Galway, Ireland-based medical device maker said it issued a field action starting July 31, notifying global customers of its MiniMed 600 series or 700 series insulin pumps to follow built-in alerts and alarms for battery status and inform the company if they noticed changes in battery life of the pump. The company first started to investigate the issue after receiving reports from customers regarding shortened battery life. It discovered that if pumps were dropped, bumped or experienced physical impact even once it could lead to shortened battery life due to damage to internal electronic components. "This may result in the pump stopping insulin delivery significantly sooner than usually expected and could lead to health risks like hyperglycemia or diabetic ketoacidosis (DKA), potentially requiring medical intervention," said Medtronic. The company has now received 170 reports of hyperglycemia and 11 reports of DKA in the period stretching from January of 2023 to September 2024 in the U.S., potentially relating to the issue. The Food and Drug Administration has classified the action as a class I recall. The stock was flat premarket but has gained 6.5% in the year to date, while the S&P 500 has gained 19.5%.
  

• Voluntary recall notifying Medtronic insulin pump users of potential risks of shortened pump battery life, from 9 hours ago by CNW Group

  9 hours ago by CNW Group
  Companies Mentioned: MDT

  COMTEX_458471026/2669/2024-10-04T06:45:34